1. Home
  2. CWAN vs RGEN Comparison

CWAN vs RGEN Comparison

Compare CWAN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CWAN
  • RGEN
  • Stock Information
  • Founded
  • CWAN 2004
  • RGEN 1981
  • Country
  • CWAN United States
  • RGEN United States
  • Employees
  • CWAN N/A
  • RGEN N/A
  • Industry
  • CWAN Computer Software: Prepackaged Software
  • RGEN Medical/Dental Instruments
  • Sector
  • CWAN Technology
  • RGEN Health Care
  • Exchange
  • CWAN Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • CWAN 7.3B
  • RGEN 8.0B
  • IPO Year
  • CWAN 2021
  • RGEN N/A
  • Fundamental
  • Price
  • CWAN $22.03
  • RGEN $118.15
  • Analyst Decision
  • CWAN Buy
  • RGEN Buy
  • Analyst Count
  • CWAN 9
  • RGEN 12
  • Target Price
  • CWAN $32.44
  • RGEN $172.67
  • AVG Volume (30 Days)
  • CWAN 3.4M
  • RGEN 819.3K
  • Earning Date
  • CWAN 04-30-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • CWAN N/A
  • RGEN N/A
  • EPS Growth
  • CWAN N/A
  • RGEN N/A
  • EPS
  • CWAN 1.71
  • RGEN N/A
  • Revenue
  • CWAN $475,948,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • CWAN $63.48
  • RGEN $13.93
  • Revenue Next Year
  • CWAN $29.35
  • RGEN $14.35
  • P/E Ratio
  • CWAN $12.87
  • RGEN N/A
  • Revenue Growth
  • CWAN 23.21
  • RGEN 4.88
  • 52 Week Low
  • CWAN $17.63
  • RGEN $102.97
  • 52 Week High
  • CWAN $35.71
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • CWAN 35.01
  • RGEN 38.20
  • Support Level
  • CWAN $23.59
  • RGEN $120.11
  • Resistance Level
  • CWAN $23.89
  • RGEN $129.42
  • Average True Range (ATR)
  • CWAN 0.56
  • RGEN 6.02
  • MACD
  • CWAN -0.07
  • RGEN -1.20
  • Stochastic Oscillator
  • CWAN 3.71
  • RGEN 5.96

About CWAN Clearwater Analytics Holdings Inc.

Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: